✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

Sartorius Stedim Biotech SA

Common Name
Sartorius Stedim Biotech
Country
France
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
10,030
Ticker
DIM
Exchange
EURONEXT
Description
Sartorius Stedim Biotech S.A. is a leading international provider of innovative equipment and services for the biopharmaceutical industry and life sciences research. The company specializes in single-...

Sartorius Stedim Biotech's GHG Emissions Data Preview

In 2025, Sartorius Stedim Biotech completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

Sartorius Stedim Biotech has also provided a category-level breakdown for 8 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.

Metric (tCO2e)202520242023
2022 - 2017
Total Scope 1
0000000
Copy/Paste is a PRO feature.
Tracenable value for the metrica
Copy/Paste is a PRO feature.
Tracenable value for the metric
0000000
Total Scope 2
Market-Based
Copy/Paste is a PRO feature.
Tracenable value for the metrica
0000000
Copy/Paste is a PRO feature.
Tracenable value for the metric
0000000
Location-Based
Copy/Paste is a PRO feature.
Tracenable value for the metrica
0000000
Copy/Paste is a PRO feature.
Tracenable value for the metric
0000000
Total Scope 3
Copy/Paste is a PRO feature.
Tracenable value for the metrica
Copy/Paste is a PRO feature.
Tracenable value for the metrica
0000000
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
0000000
Copy/Paste is a PRO feature.
Tracenable value for the metrica
Copy/Paste is a PRO feature.
Tracenable value for the metric
0000000
Limited Data Preview
You are viewing a limited preview of Sartorius Stedim Biotech’s GHG emissions dataset. The full dataset, available for download, includes Scope 1, 2, and 3 emissions with detailed category-level breakdowns, historical coverage back to 2024, and revenue-based intensity metrics for each scope.
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=DIM&reporting_period=2025"

Verified Sources Behind Sartorius Stedim Biotech’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Sartorius Stedim Biotech’s data sources below and access millions more through our Disclosure Search.

a. Sartorius Stedim Biotech's Universal Registration Document (URD) 2025

Insights into Sartorius Stedim Biotech's Operational Emissions

In 2025, the total operational greenhouse gas (GHG) emissions of Sartorius Stedim Biotech amounted to 63,427 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Compared to 2024, the total operational greenhouse gas (GHG) emissions of Sartorius Stedim Biotech increased by 8.91%, suggesting that the company faced challenges in reducing its emissions from its core operations.a

Sartorius Stedim Biotech's Scope 1 Emissions Over Time

2024202504.5 k9 k13.5 k18 ktCO2e+17%
  • Total Scope 1
  • Year-over-Year Change

What are Sartorius Stedim Biotech's Scope 1 emissions?

In 2025, the total Scope 1 emissions of Sartorius Stedim Biotech were 16,026 metric tons of CO₂ equivalent (tCO₂e).a

Compared to the previous year (2024), Sartorius Stedim Biotech's Scope 1 emissions increased by 17.13%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.a

What are Sartorius Stedim Biotech's Scope 2 emissions?

In 2025, Sartorius Stedim Biotech reported Scope 2 greenhouse gas (GHG) emissions of 29,279 tCO₂e using the market-based method and 47,401 tCO₂e using the location-based method.a

Has Sartorius Stedim Biotech reduced its Scope 2 emissions over time?

Compared to the previous year (2024), Sartorius Stedim Biotech's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that Sartorius Stedim Biotech's emissions have plateaued with no significant change in its energy consumption footprint.a

What methodology does Sartorius Stedim Biotech use for Scope 2 reporting?

In 2025, Sartorius Stedim Biotech reported its Scope 2 emissions using the market-based method and using the location-based method.a

Sartorius Stedim Biotech's Scope 2 Emissions Over Time

20242025015 k30 k45 k60 ktCO2e
  • Total Scope 2 Location-Based
  • Total Scope 2 Market-Based

Insights into Sartorius Stedim Biotech's Value Chain Emissions

In 2025, Sartorius Stedim Biotech reported 403,532 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a

The 2025 disclosure of Sartorius Stedim Biotech includes a breakdown across 8 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2024, demonstrating consistent Scope 3 emissions reporting coverage year over year.a

Sartorius Stedim Biotech's Scope 3 Emissions Over Time

202420250150 k300 k450 k600 ktCO2e+5%
  • Total Scope 3
  • Year-over-Year Change

What are Sartorius Stedim Biotech's Scope 3 emissions?

In 2025, Sartorius Stedim Biotech reported total Scope 3 emissions of 403,532 metric tons of CO₂ equivalent (tCO₂e).a

Approximately 80.46% of these emissions originated from upstream activities such as purchased goods and capital goods, while 19.54% came from downstream activities like product use, distribution, and end-of-life treatment.a

Compared to the previous year (2024), Sartorius Stedim Biotech's Scope 3 emissions remained relatively stable, indicating that Sartorius Stedim Biotech's emissions have plateaued with no significant change in its value chain footprint.a

What categories of Scope 3 emissions does Sartorius Stedim Biotech disclose?

In 2025, Sartorius Stedim Biotech reported emissions for 8 out of the 15 Scope 3 categories defined by the GHG Protocol.a

This partial disclosure allows for some insight into the company's indirect impacts.

What are the main sources of Sartorius Stedim Biotech's Scope 3 emissions?

In 2025, the largest contributors to Sartorius Stedim Biotech's Scope 3 emissions were:a

  • Purchased Goods and Services (Cat. 1): 155,465 tCO₂e (38.53%)
  • Upstream Transportation and Distribution (Cat. 4): 73,327 tCO₂e (18.17%)
  • Capital Goods (Cat. 2): 70,268 tCO₂e (17.41%)

Sartorius Stedim Biotech's Scope 3 Emissions by Categories

Purchased Goods andServices (Cat. 1)(38.5%)Capital Goods(Cat. 2)(17.4%)UpstreamTransportation andDistribution(Cat. 4)(18.2%)

Insights into Sartorius Stedim Biotech’s GHG Emissions Intensity Compared to Industry Peers

In 2025, Sartorius Stedim Biotech reported Scope 1 greenhouse gas (GHG) emissions of 16,026 tCO₂e and total revenues of USD 3,489 millions. This translates into an emissions intensity of 4.59 tCO₂e per millions USD.a

Sartorius Stedim Biotech's Scope 1 Emissions Intensity Compared to Peers

51002,00050,0001,000,000Scope 1 Emissions (tCO2e)505002,00010,000100,000Revenues (Millions of USD)ISResmedYear: 2025Scope 1: 3,957 tCO2eRevenue: $M 5,146Scope 1 Intensity: 0.77 tCO2e/$MColoplastYear: 2024Scope 1: 17,514 tCO2eRevenue: $M 4,038Scope 1 Intensity: 4.34 tCO2e/$MAptargroupYear: 2024Scope 1: 24,805 tCO2eRevenue: $M 3,583Scope 1 Intensity: 6.92 tCO2e/$MHoyaYear: 2024Scope 1: 17,000 tCO2eRevenue: $M 5,234Scope 1 Intensity: 3.25 tCO2e/$MTerumoYear: 2023Scope 1: 64,123 tCO2eRevenue: $M 6,158Scope 1 Intensity: 10.41 tCO2e/$MAvantorYear: 2024Scope 1: 39,502 tCO2eRevenue: $M 6,784Scope 1 Intensity: 5.82 tCO2e/$MAlconYear: 2024Scope 1: 74,202 tCO2eRevenue: $M 7,655Scope 1 Intensity: 9.69 tCO2e/$MBausch + LombYear: 2024Scope 1: 51,517 tCO2eRevenue: $M 4,791Scope 1 Intensity: 10.75 tCO2e/$MWarby ParkerYear: 2023Scope 1: 961 tCO2eRevenue: $M 670Scope 1 Intensity: 1.43 tCO2e/$MCarl Zeiss MeditecYear: 2025Scope 1: 8,046 tCO2eRevenue: $M 2,614Scope 1 Intensity: 3.08 tCO2e/$MBaxter InternationalYear: 2024Scope 1: 324,000 tCO2eRevenue: $M 10,636Scope 1 Intensity: 30.46 tCO2e/$MConvaTec GroupYear: 2024Scope 1: 12,360 tCO2eRevenue: $M 2,289Scope 1 Intensity: 5.40 tCO2e/$MTeleflexYear: 2024Scope 1: 16,256 tCO2eRevenue: $M 3,047Scope 1 Intensity: 5.33 tCO2e/$MMerit Medical SystemsYear: 2024Scope 1: 2,875 tCO2eRevenue: $M 1,357Scope 1 Intensity: 2.12 tCO2e/$MIIImeik Technology DevelopmentYear: 2024Scope 1: 1,252 tCO2eRevenue: $M 415Scope 1 Intensity: 3.02 tCO2e/$MColtene HoldingYear: 2025Scope 1: 1,672 tCO2eRevenue: $M 303Scope 1 Intensity: 5.52 tCO2e/$MWeigao GroupYear: 2024Scope 1: 3,096 tCO2eRevenue: $M 1,793Scope 1 Intensity: 1.73 tCO2e/$MEssilorluxotticaYear: 2024Scope 1: 116,092 tCO2eRevenue: $M 27,584Scope 1 Intensity: 4.21 tCO2e/$MAngelalign TechnologyYear: 2023Scope 1: 8 tCO2eRevenue: $M 210Scope 1 Intensity: 0.04 tCO2e/$MSSSupermaxYear: 2025Scope 1: 147,054 tCO2eRevenue: $M 185Scope 1 Intensity: 794.16 tCO2e/$MSri Trang Gloves Thailand CoYear: 2024Scope 1: 58,944 tCO2eRevenue: $M 728Scope 1 Intensity: 80.95 tCO2e/$MEnvista HoldingsYear: 2024Scope 1: 3,000 tCO2eRevenue: $M 2,511Scope 1 Intensity: 1.19 tCO2e/$MIntuitive SurgicalYear: 2024Scope 1: 8,105 tCO2eRevenue: $M 8,352Scope 1 Intensity: 0.97 tCO2e/$MHologicYear: 2024Scope 1: 7,050 tCO2eRevenue: $M 4,030Scope 1 Intensity: 1.75 tCO2e/$MSartorius Stedim BiotechYear: 2025Scope 1: 16,026 tCO2eRevenue: $M 3,489Scope 1 Intensity: 4.59 tCO2e/$M

How does Sartorius Stedim Biotech's GHG emissions intensity compare to its peers?

In 2025, Sartorius Stedim Biotech reported a Scope 1 emissions intensity of 4.59 tCO₂e per millions USD. Compared to the peer group median of 4.27, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a

Where does Sartorius Stedim Biotech rank on GHG emissions intensity within its industry?

In 2025, Sartorius Stedim Biotech ranked 14 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a

Sartorius Stedim Biotech is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a

Insights into Sartorius Stedim Biotech's Total Carbon Footprint

In 2025, Sartorius Stedim Biotech reported a total carbon footprint of 466,959 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 5.13% increase compared to 2024, suggesting a rise in emissions across its operations or value chain.a

The largest contributor to Sartorius Stedim Biotech's total carbon footprint was Scope 3 emissions, accounting for 86.42% of the company's total carbon footprint, followed by Scope 2 emissions at 10.15%.a

Want Full Access to Sartorius Stedim Biotech's GHG Emissions Dataset?
Start 30-Day Free Trial